Medical/Pharmaceuticals

Infinitus Earns Prestigious Mercer China Healthiest Workplace Title and the Outstanding Health Innovation Award

GUANGZHOU, China, July 20, 2024 /PRNewswire/ -- On July 18th, as the 2024-2025 Mercer China Healthiest Workplace List was unveiled, Infinitus received the prestigious "Mercer China Healthiest Workplace" designation and the Outstanding Health Innovation Award.

2024-07-20 03:26 4980

Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration

SHENZHEN, China, July 19, 2024 /PRNewswire/ -- On July 19, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences") announced that it has received the Drug Registration Certificate approved and issued by the National Medical Products Administration (NMPA) fo...

2024-07-19 22:01 4825

New Paper Underscores Inflammation's Role in Atherosclerosis

Understanding the Effect of Inflammation is Key for Early Intervention, Reducing Adverse Cardiovascular Outcomes WASHINGTON, July 19, 2024 /PRNewswire/ -- The International Atherosclerosis Society today released a clinical proceedingswhite paper outlining the role of inflammation in atherosclero...

2024-07-19 21:00 1655

111 Announces Appointment of New Auditor

SHANGHAI, July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced  the appointment o...

2024-07-19 20:45 3051

Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms

* Financing led by LongRiver Investments with participation by new and existing global investment funds * Rona will use proceeds to progress leading metabolic siRNA pipeline programs into global development and expand extra-hepatic delivery platform in CNS and beyond SHANGHAI, July 19, 2024 /...

2024-07-19 12:30 2707

Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 18, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-07-19 07:15 2843

VARON Enters CPAP and BiPAP Machine Market with Feature-Rich "Sunny Grand" Series

SEATTLE, July 18, 2024 /PRNewswire/ -- VARON , a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line ofCPAP (continuous positive airway pressure)

2024-07-19 01:30 1346

ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development

NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting inHamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of accelerating the advancement of cell and gene therapy (CGT) developme...

2024-07-19 00:00 2237

Assessment of supply chain risk key to improving medicine access

A four-year research project by INSEAD and five other institutions sheds light on how understandingmedical criticality, supply chain risk and their interactions could help us better address drug shortages. FONTAINEBLEAU, France, SINGAPORE and SAN FRANCISCO, July 18, 2024 /PRNewswire/ -- Drug s...

2024-07-18 23:00 2187

DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment

* Confirmation of effects compared to global late-stage clinical trials * Accelerating the development of obesity treatment through early licensing out, global joint clinical trials, research funding investment, etc. SEOUL, South Korea, July 18, 2024 /PRNewswire/ -- DX&VX, which is gaining att...

2024-07-18 21:00 2406

Duoning showcases its comprehensive bioprocess solutions at Interphex Korea 2024

SHANGHAI, July 18, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess solution provider, announced it has attended at Interphex Korea 2024 to showcase its total bioprocess solutions for the preparation of diverse biological products. Interphex 2024 provide...

2024-07-18 20:00 1943

BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards

Recognized for excellence in writing, news, mental health, financial/investment and economics categories LONDON, July 18, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has been honored with nine2024 APEX Awards fo...

2024-07-18 15:00 1765

Pfizer's First Dual Indication Vaccine for Respiratory Syncytial Virus (RSV) is Available This Month in Hong Kong

* The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B has been approved by health authorities inHong Kong and Macau earlier, and is available inHong Kong this month (July 2024) * Helps fight against RSV in older adults aged 60 and above and infants (throu...

2024-07-18 14:41 1848

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

GOTHENBURG, Sweden, July 18, 2024 /PRNewswire/ -- "Net sales increased by 15.7% in the second quarter, of which the organic increase was 8.9%," says Mattias Perjos, President & CEO at Getinge. "The operating margin improved compared with last year due to strong sales and a positive product mix, w...

2024-07-18 14:33 1747

MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference

* MicuRx showcased the latest research progress on their pipeline products, MRX-5 and MRX-8, at the 7th World Bronchiectasis Conference * Three significant study results further support the potential of MRX-5 and MRX-8 in treating Nontuberculous Mycobacteria (NTM) lung disease and Pseudomonas...

2024-07-18 13:19 1294

VitalLife and Bumrungrad International Hospital in Thailand Launch NEC's FonesVisuas Test: First Major Deployment Outside Japan, Revolutionizing Disease Risk Prediction

BANGKOK, July 18, 2024 /PRNewswire/ -- VitalLife Scientific Wellness Center, a subsidiary of Bumrungrad International Hospital inBangkok, Thailand, recognized as one of Newsweek's World's Best Hospitals for four consecutive years (2021-2024) and NEC Corporation (NEC; TSE: 6701), a leader in IT, n...

2024-07-18 10:00 2151

PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosystem with Fourth Site and Extended Awards Programme

* The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem, with a doubling of applicants compared to last year * Amgen and NSG BioLabs extended the Golden Ticket partnership for another three y...

2024-07-18 10:00 3118

China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products

SHENZHEN, China, July 18, 2024 /PRNewswire/ -- The 90th China International Medical Equipment Fair (CMEF) is set to take place inShenzhen from October 12th to 15th, 2024. With an expected attendance of over 200,000 visitors from more than 150 countries, the exhibition is poised to be a global sho...

2024-07-18 09:50 2744

Everest Medicines Announces Official Acceptance Granted on NEFECON® Supplementary Application by China National Medical Products Administration

SHANGHAI, July 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced thatChina's National Medical Products ...

2024-07-18 08:00 2036

Telix Pharmaceuticals Q2 2024 Revenue and Business Highlights, Guidance Upgrade

MELBOURNE, Australia, July 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended30 June 2024 (Q2 2024). Q2 2024 Financial Performance and Guidance Upgrade   The Company rep...

2024-07-18 07:17 2026
1 ... 43444546474849 ... 610

Week's Top Stories